Document
IPR2016-01131, No. 1168-266 Exhibit - Exhibit 1168 Transcript of March 5, 2018 Call (P.T.A.B. Mar. 8, 2018)
Cite Document
IPR2016-01131, No. 1168-266 Exhibit - Exhibit 1168 Transcript of March 5, 2018 Call (P.T.A.B. Mar. 8, 2018)
+ More Snippets
Document
IPR2016-01131, No. 1147-230 Exhibit - EX1147 IamMedia (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01131, No. 1147-230 Exhibit - EX1147 IamMedia (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1057-104 Exhibit - Exhibit 1057 Glenn (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1057-104 Exhibit - Exhibit 1057 Glenn (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1059-106 Exhibit - Exhibit 1059 Foulks et al 2007 DEWS dry eye study report (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1059-106 Exhibit - Exhibit 1059 Foulks et al 2007 DEWS dry eye study report (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1069-116 Exhibit - Exhibit 1069 Orange Book Restasis (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1069-116 Exhibit - Exhibit 1069 Orange Book Restasis (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1048-95 Exhibit - Exhibit 1048 Garralt 2011 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1048-95 Exhibit - Exhibit 1048 Garralt 2011 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2030-47 Exhibit - FDA Review The Drug Development and Approval Process (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2030-47 Exhibit - FDA Review The Drug Development and Approval Process (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2006-11 Exhibit - Dorlands Illustrated Medical Dictionary (P.T.A.B. Sep. 9, 2016)
Cite Document
IPR2016-01131, No. 2006-11 Exhibit - Dorlands Illustrated Medical Dictionary (P.T.A.B. Sep. 9, 2016)
+ More Snippets
Document
IPR2016-01131, No. 1067-114 Exhibit - Exhibit 1067 Restasis MultiDose Label 102016 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1067-114 Exhibit - Exhibit 1067 Restasis MultiDose Label 102016 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1032-84 Exhibit - Exhibit 1032 Orange Book 29th Eddition 2009 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1032-84 Exhibit - Exhibit 1032 Orange Book 29th Eddition 2009 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2052-63 Exhibit - Allergan Inc, Morgan Stanley Equity Research Report, Apr 30, 2004 (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2052-63 Exhibit - Allergan Inc, Morgan Stanley Equity Research Report, Apr 30, 2004 (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2033-50 Exhibit - Drugs at FDA FDA Approved Drug Products, Restasis Approved (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2033-50 Exhibit - Drugs at FDA FDA Approved Drug Products, Restasis Approved (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2050-62 Exhibit - Allergan Inc, Morgan Stanley Equity Research Report, Jan 30, 2003 (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2050-62 Exhibit - Allergan Inc, Morgan Stanley Equity Research Report, Jan 30, 2003 (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2066-66 Exhibit - Sales Units 2011 2016 AllData NSP Feb 19 2017 RESTASIS (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2066-66 Exhibit - Sales Units 2011 2016 AllData NSP Feb 19 2017 RESTASIS (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1166-261 Exhibit - Exhibit 1166 October 11 2017 email chain (P.T.A.B. Nov. 22, 2017)
Cite Document
IPR2016-01131, No. 1166-261 Exhibit - Exhibit 1166 October 11 2017 email chain (P.T.A.B. Nov. 22, 2017)
+ More Snippets